1. TANG , M. , SONG , P. and HE , J. 2019. Progress on drug pricing negotiations in China. BioScience Trends, 13(6) , pp. 464 - 468 . TANG, M., SONG, P. and HE, J. 2019. Progress on drug pricing negotiations in China. BioScience Trends, 13(6), pp.464-468.
2. FAN C. WANG L. and WU J. 2020. Discussion on improving the access of innovative drugs under the background of dynamic adjustment of medical insurance catalogue. China Health Insurance (05):63-67. FAN C. WANG L. and WU J. 2020. Discussion on improving the access of innovative drugs under the background of dynamic adjustment of medical insurance catalogue. China Health Insurance (05):63-67.
3. Progress and Reflection on the reform of medical insurance payment for innovative drugs in China;WANG H.;Health Economics Research,2021
4. The Work Plan for the Adjustment of the National Medical Insurance Drug Catalogue (Draft for Comments) 2020. National Healthcare Security Administration China. The Work Plan for the Adjustment of the National Medical Insurance Drug Catalogue (Draft for Comments) 2020. National Healthcare Security Administration China.
5. Decryption of national drug negotiations;ZHANG M.;China Social Security,2017